Mesna is typically administered alongside high-dose ifosfamide and, in some cases, high-dose cyclophosphamide, especially when these drugs are used in the treatment of cancers such as sarcomas, germ cell tumors, and lymphomas. The use of mesna is crucial in these contexts as it helps to prevent serious complications, allowing patients to continue with effective chemotherapy regimens without disruption due to bladder toxicity.
